COVID-19

In this webinar, moderated by Daniel Siegel, M.D., M.A., FAAD, FACMS, experts discuss guidance on the use of teledermatology and ways to successfully implement new models of care during the COVID-19 pandemic.

Eighteen residents and fellows in the throes of their dermatology training volunteered at the frontlines of overwhelmed Bronx-based hospitals during the height of the COVID-19 pandemic, gaining a crash course in crisis medicine and infectious diseases.

In the COVID-19 era, standard of care is still evolving. David J. Goldberg, M.D., J.D., discusses this and more liability issues to consider when re-opening your practice.

In part one of our video interview with Iltefat H. Hamzavi, M.D., he discusses how ultraviolet germicidal irradiation is used in dermatology and how it can be used to disinfect N95 respirators to facilitate reuse during the COVID-19 pandemic.

Dermatology patients are hungry for information that will ensure their safety during the COVID-19 pandemic, notes Vivian Shi, M.D. In this video, she discusses how to address patients' varying concerns in this uncertain time.

Part three of our interview with Amy Paller, M.D., focuses on the emergence of a multisystem inflammatory syndrome in children (MIS-C), what we know about this novel condition and its relationship to COVID-19.

DermYoung and Eden MedSpa announce the launch of their “Together We Are Love, Together We Will Heal,” campaign which aims to provide NYC first responders with facials and take-home skincare kits for those experiencing skin damage and irritation due to PPE usage.

In light of the ongoing pandemic, Vivian Shi, M.D., discusses potential risks dermatologists will want to keep in mind when evaluating patients currently taking immunomodulator or immunosuppressant drugs.

Bluestone Sunshields is helping fill the gaps of PPE available to those working on the frontlines of the COVID-19 pandemic by converting their UV ray-blocking visors into clear face shields.

In part two of our interview with Amy Paller, M.D., she describes how she is staying informed about the latest COVID-19 research as it relates to the field, and shares some resources other dermatologists may find helpful during this crisis.

DMK Skin Care announces the donation of their new sanitizer spray for all licensed clinics. The product is optimized to sanitize clothing, surfaces and skin.

Amy Paller, M.D., discusses the pernio-like lesions associated with possible COVID-19 infection in younger individuals.

A third-year resident in the department of dermatology at the University of California, Irvine has kicked off a passion project turning discarded sterilization wrap into face masks with a high filter efficiency. She hopes these will fill a need as well as reserve N95 masks and surgical masks for those procedures that they are designated.

The U.S. FDA has granted an emergency use authorization to Everlywell Inc., to conduct and collect at-home testing for COVID-19.

As states begin to reopen-and patients return to healthcare providers-you, your team and your patients likely have a lot of questions regarding what the post-COVID-19 healthcare experience will be like. You can take these steps to alleviate team safety concerns and communicate safety changes to patients.

The American Academy of Dermatology (AAD) announces the debut of their AAD VMX 2020, a virtual meeting being held June 12-14 in lieu of the annual AAD conference that was set to take place in March in Denver but cancelled due to COVID-19 concerns.

A new way to avoid contact with contaminated surfaces is now available through 5th Axis, a San Diego, Calif.-based machinery manufacturer. The company has created the StepHandle, a door handle that can be operated with a foot.

This week, we spoke with Mark Lebwohl, M.D., about his recent article featured in the Journal of the American Academy of Dermatology regarding biologic use in dermatology patients during the COVID-19 pandemic.

Gilead announces results from their phase 3 trial investigating different dosing durations for the investigational antiviral drug remdesivir.

Read one New York physician's insights on practice survival and patient care during the pandemic.

David J. Goldberg, M.D., J.D., discusses important considerations regarding telemedicine and HIPAA compliance that dermatologists should keep in mind during the COVID-19 pandemic.

A new symptom is popping up in COVID-19 patients. The virus can reportedly affect not only the lungs, but other internal organs as well as the senses – and now dermatologists are observing skin reactions in patients with the disease.

George Martin, M.D., dermatologist and program director for the Maui Derm meetings, has been working with the Maui Derm faculty, immunologists and members of industry to share emerging data regarding the novel coronavirus with the dermatology community. Listen to his insights in this video.

The coronavirus has created a challenging environment for all dermatology practices. Todd Petersen, CEO of VitalSkin Dermatology, discusses how to make the most of a bad situation by using telemedicine, making plans to reopen and performing a strategic review of your practice. 

In combatting the pandemic, dermatologists must take critical steps to adapt operations while still providing essential patient care and preventing exposure in office settings, experts say.